Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Penederm receives SBIR grant for research on vitamin D derivative

June 5, 1997

Bristol-Myers Squibb selects diacid for development as antipsoriatic

June 4, 1997

ProCyte launches GraftCyte products

May 28, 1997

Dusa reports progress in phase III trial of Levulan PDT

May 23, 1997

VIMRx acquires worldwide rights to wound-healing agent

May 21, 1997

Ointment formulation of BioCryst's BCX-34 enters phase II for psoriasis

May 20, 1997

Safety, pharmacological, phase I and early phase II results for SM-10902

May 20, 1997

CytoMed initiates phase II trials of CMI-392

May 9, 1997

Dermik introduces combination acne therapy in South Africa

May 9, 1997

FDA advisory panel denies approval for Genzyme's Sepracoat

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...